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Correlation between case mix index and antibiotic use in
hospitals
Abstract
BACKGROUND: To compare the quantitative antibiotic use between hospitals or hospital units and to
explore differences, adjustment for severity of illness of hospitalized patients is essential. The case mix
index (CMI) is an economic surrogate marker (i.e. the total cost weights of all inpatients per a defined
time period divided by the number of admissions) to describe the average patients' morbidity of
individual hospitals. We aimed to investigate the correlation between CMI and hospital antibiotic use.
METHODS: We used weighted linear regression analysis to evaluate the correlation between in-hospital
antibiotic use in 2006 and CMI of 18 departments of the tertiary care University Hospital Zurich and of
10 primary and 2 secondary acute care hospitals in the Canton of Zurich in Switzerland. RESULTS:
Antibiotic use varied substantially between different departments of the university hospital [defined
daily doses (DDD)/100 bed-days, 68.04; range, 20.97-323.37] and between primary and secondary care
hospitals (range of DDD/100 bed-days, 15.45-57.05). Antibiotic use of university hospital departments
and the different hospitals, respectively, correlated with CMI when calculated in DDD/100 bed-days
[coefficient of determination (R(2)), 0.57 (P = 0.0002) and 0.46 (P = 0.0065)], as well as when
calculated in DDD/100 admissions [R(2), 0.48 (P = 0.0008) and 0.85 (P < 0.0001), respectively].
CONCLUSIONS: Antibiotic use correlated with CMI across various specialties of a university hospital
and across different acute care hospitals. For benchmarking antibiotic use within and across hospitals,
adjustment for CMI may be a useful tool in order to take into account the differences in hospital
category and patients' morbidities.
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ABSTRACT (247 words) 27 
Background: To compare the quantitative antibiotic use between hospitals or 28 
hospital units and to explore differences, adjustment for severity of illness of 29 
hospitalized patients is essential. The case mix index (CMI) is an economical 30 
surrogate marker (i.e., the total cost weights of all inpatients per a defined time period 31 
divided by the number of admissions) to describe the average patients' morbidity of 32 
individual hospitals. We aimed to investigate the correlation between CMI and 33 
hospital antibiotic use. 34 
Methods: We used weighted linear regression analysis to evaluate the correlation 35 
between in-hospital antibiotic use in 2006 and CMI of 18 departments of the tertiary 36 
care University Hospital Zurich, and of ten primary and two secondary acute care 37 
hospitals in the Canton of Zurich in Switzerland. 38 
Results: Antibiotic use varied substantially between different departments of the 39 
university hospital (mean defined daily dose (DDD)/100 bed-days, 68.04; range 40 
20.97 - 323.37) and between primary and secondary care hospitals (range of mean 41 
DDD/100 bed-days, 15.45 - 57.05). Antibiotic use of university hospital departments 42 
and the different hospitals, respectively, correlated with CMI when calculated in 43 
DDD/100 bed-days (coefficient of determination (R2), 0.57 (p = 0.0002) and 0.46 (p = 44 
0.0065)), as well as when calculated in DDD/100 admissions (R2, 0.48 (p = 0.0008) 45 
and 0.85 (p < 0.0001), respectively). 46 
Conclusions: Antibiotic use correlated with CMI across various specialties of a 47 
university hospital and across different acute care hospitals. For benchmarking 48 
antibiotic use within and across hospitals, adjustment for CMI may be a useful tool in 49 
order to take into account differences in hospital category and patients' morbidities. 50 
 51 
   
INTRODUCTION 52 
Increased and inappropriate antibiotic use among outpatients and in hospitals has 53 
been noted worldwide,1-4 and the association between antibiotic use and the 54 
emergence of antibiotic resistance is well established.5-7 Antibiotic stewardship 55 
programs in hospitals are considered a major tool to address these problems.8 The 56 
quantitative and qualitative assessment of antibiotic use is crucial to develop 57 
antibiotic policies and is a mainstay of antibiotic stewardship programs. The amount 58 
of antibiotic use has been found to vary widely across countries in the ambulatory as 59 
well as the hospital setting.9, 10 Reasons for these variations may include different 60 
antibiotic policies, physicians' education, culture-dependent patients' expectations, 61 
varying antibacterial resistance rates and differences in measuring antibiotic use. The 62 
ATC/DDD system promoted by the World Health Organization is the standard 63 
method for reporting antibiotic use.11 However, different formats for measuring and 64 
reporting antibiotic use are still applied in the current literature.1, 4, 12, 13 65 
Clinicians often justify high antibiotic use in their particular setting with differences 66 
in patients' morbidities. Several scores are used to classify patients' severity of illness 67 
based on their co-morbidities in clinical studies,14, 15 but, unfortunately, there is no 68 
straightforward tool to routinely obtain morbidity scores for all inpatients of an entire 69 
hospital. Using economical hospital data might be an approach to systematically 70 
account for co-morbidities. The case mix index (CMI) is such an economical 71 
parameter, which is calculated using diagnosis related groups (DRGs), a measure 72 
that is nowadays routinely obtained in various countries as a basis for hospital 73 
reimbursement.16 74 
DRGs, developed as an instrument to relate the case mix of a hospital to the 75 
costs, classify patients depending on their diagnosis, treatments, age and other 76 
informations into mutually exclusive, clinically and financially homogeneous 77 
   
categories. This is done by collecting information about a patient's medical needs 78 
and subsequently converting this information into codes. These codes describe 79 
patients' conditions, their severity of illness, and their prognoses.17 DRGs were first 80 
developed in the 1960s at Yale University.16, 18 Since then, DRGs or similar grouping 81 
systems have been installed by most European countries. Most classification 82 
methods are based to some extent on the Health Care Financing Administration 83 
(HCFA) system that was introduced in 1983 under the US Medicare system. Despite 84 
this similarity, there are considerable differences in the methods for collecting cost 85 
data and reimbursement rates among different countries.16, 19 Nevertheless, DRGs 86 
are a useful and simple tool for defining and measuring a hospital’s case mix 87 
complexity. 88 
Associations between CMI and antibiotic use have been studied in long-term care 89 
settings,20, 21 but neither in large university hospitals with a wide variation of antibiotic 90 
use and CMIs across different departments, nor across various acute care hospitals. 91 
We therefore aimed to evaluate the correlation between antibiotic use and CMI in 92 
these two settings. 93 
   
METHODS 94 
Study Design 95 
We performed a retrospective observational study of antibiotic use and CMI in 96 
different departments of the University Hospital Zurich and in another twelve acute 97 
care hospitals in the Canton of Zurich, a state in Switzerland, during the study period 98 
between January 1, 2006 and December 31, 2006.  99 
 100 
Case Mix Index (CMI) 101 
The CMI equals the sum of the total cost weights of all inpatients per a defined 102 
time period divided by the number of admissions. The 'cost weight' of a diagnosis 103 
related group (DRG) X is defined by dividing the average cost per case of DRG X by 104 
the mean cost per case on a nationwide level. In this way, each DRG is allocated a 105 
cost weight. In Switzerland, cost weights are regularly recalculated and recorded in 106 
the database of APDRG Swiss.22 107 
 108 
Setting  109 
The University Hospital Zurich is a 861 beds tertiary care teaching hospital. It 110 
covers all specialties except paediatrics and orthopaedics. The psychiatry ward was 111 
excluded from the analysis since cost weights for psychiatric patients have not yet 112 
been defined in Switzerland. 1,959 healthy newborns were cared for in the obstetrics 113 
department. In addition, the same department included a 23-beds neonatology ward. 114 
Six intensive care units, including a burn unit, with a total of 59 beds are assigned to 115 
different departments. Bone marrow transplantations are performed in a specialized 116 
unit. In 2006, a total of 33,663 patients were admitted accounting for 243,235 bed-117 
days (day of admission and day of discharge counted together as one bed-day).23 118 
   
The mean length of stay in the wards, the ICUs and the bone marrow transplantation 119 
unit was 4.6 (range, 3.0-11.5), 3.7 (range, 3.1-5.8), and 20.8 days, respectively.  120 
The other twelve hospitals of the Canton of Zurich included ten primary and two 121 
secondary care hospitals. In 2006, the numbers of beds of these hospitals ranged 122 
from 92 to 554, the number of intensive care beds from 4 to 16, the numbers of bed-123 
days (day of admission and day of discharge counted together as one bed-day) from 124 
22,521 to 152,674, the number of patients admitted from 3,705 to 21,229, and the 125 
mean length of stay from 4.3 to 18.4 days. An obstetrics department was part of all 126 
but one of the hospitals with numbers of newborns ranging from 321 to 1,463. 127 
Paediatric wards were part of one primary care hospital and both secondary care 128 
hospitals. Two primary care hospitals included a long-term care unit, one a psychiatry 129 
ward. None of the hospitals had a rehabilitation ward.23 Most of the 13 hospitals had 130 
internal guidelines for antibiotic use.  131 
 132 
Data collection  133 
For the University Hospital Zurich, aggregate in-hospital antibiotic use data, 134 
including deliveries and returns, were collected from the hospital pharmacy and 135 
entered into a Microsoft® Office Access 2003 database similar to the ABC Calc 136 
developed by the Danish Statens Serum Institut.24 Bed-days and numbers of 137 
admissions were calculated from computerised hospital administration records of 138 
each patient hospitalized for ≥24 hours in the same hospital unit, counting the days of 139 
admission and discharge together as one bed-day. Defined daily doses (DDD) per 140 
100 bed-days and DDD per 100 admissions were calculated for each hospital 141 
department. The 2007 version (Group 'J01 (Antibacterials for systemic use)') of the 142 
ATC Index with DDDs was used.11  143 
   
CMIs for patients hospitalized in these defined patient care areas were calculated 144 
for the study year, using data provided by the Division of Medical Coding Statistics of 145 
the University Hospital Zurich based on cost weights for each patient. Version 1.6 of 146 
the APDRG Grouper and Version 5.1 of the Swiss APDRG costweights were used.22 147 
Diagnoses were coded with the ICD-10 WHO Version 1.3 and treatments were 148 
coded with CHOP Version 8.0, a Swiss translation of ICD-9-CM 2005. Cost weights 149 
of patients that were transferred between hospital departments were counted for the 150 
calculation of CMI of each location, accordingly.  151 
For the other twelve hospitals of the Canton of Zurich, numbers of bed-days, 152 
admissions and CMIs are published on a yearly basis by the health care authorities 153 
of the Canton of Zurich.23 Cumulative antibiotic use data for the year 2006 were 154 
obtained from the hospital pharmacy of each hospital. Calculations of antibiotic use 155 
data were carried out in analogy to the methods described above. The analyses were 156 
limited to somatic acute care units of the hospitals (excluding long-term care units), 157 
except for one hospital, where a psychiatry ward and a long-term care unit could not 158 
be excluded due to local pharmacy data management reasons. 159 
 160 
Statistical analysis 161 
We used Stata (Version 9.2, StataCorp, College Station, Texas) for statistical 162 
analyses. Weighted linear regression analyses  were performed to determine the 163 
correlation between antibiotic use and CMI. We used analytic weights according to 164 
the number of bed-days of each department or hospital to reduce variation induced 165 
by measures derived from smaller hospitals or departments.  A P value <0.05 was 166 
considered statistically significant. 167 
   
RESULTS 168 
Antibiotic use 169 
Antibiotic use data are depicted in Figure 1, and data on length of stay in different 170 
hospitals are listed in the figure legend. At the university hospital, overall antibiotic 171 
use was 68.04 DDD/100 bed-days and 491.62 DDD/100 admissions, respectively. 172 
The DDD/100 bed days in the intensive care units ranged from 101.31 to 176.23, and 173 
in the wards from 20.97 to 112.18. The highest antibiotic use with 323.37 DDD/100 174 
bed-days was recorded in the bone marrow transplantation unit (Figure 1A). 175 
In primary care hospitals, antibiotic use ranged from 15.45 to 57.05 DDD/100 bed-176 
days and from 182.95 to 405.21 DDD/100 admissions (Figure 1B). The 177 
corresponding numbers for the two secondary care hospitals were 39.46  and 50.56 178 
DDD/100 bed-days and 268.59 and 383.77 DDD/100 admissions, respectively.  179 
 180 
Correlation between antibiotic use and CMI at the University Hospital 181 
The CMI of the various units and departments described above ranged from 3.57 182 
to 6.45 in the intensive care units and from 1.01 to 3.02 on general wards. A CMI of 183 
9.83 was calculated for the bone marrow transplantation unit. The correlation 184 
between antibiotic use and CMI is depicted in Figure 2. We found a significant 185 
correlation between CMI and antibiotic use when calculated in DDD/100 bed-days 186 
(R2 = 0.57, p = 0.0002, slope = 27.90 DDD/100 bed-days per CMI (95% CI 15.71 - 187 
40.08)) as well as in the DDD/100 admissions format (R2 = 0.48, p = 0.0008, slope = 188 
383.61 DDD/100 admissions per CMI (95% CI 186.18 - 581.05)).  189 
 190 
Correlation of antibiotic use and CMI at the 13 hospitals of the Canton of Zurich 191 
The CMI of the ten primary, the two secondary care hospitals and the tertiary care 192 
University Hospital ranged from 0.7853 to 1.3624. Correlations between antibiotic 193 
   
use and CMI across various hospitals of the greater Zurich area are displayed in 194 
Figure 3. There was a significant correlation between CMI and antibiotic use 195 
presented in the DDD/100 bed-days format (R2 = 0.46, p = 0.0065, slope = 47.96 196 
DDD/100 bed-days per CMI (95% CI 16.46 - 79.47)) as well as in the DDD/100 197 
admissions format (R2 = 0.85, p < 0.0001, slope = 403.25 DDD/100 admissions per 198 
CMI (95% CI 295.00 - 511.51)). 199 
   
DISCUSSION 200 
The direct comparison of the quantity of antibiotic use between hospitals or 201 
hospital units is flawed due to differences in the average severity of illness of patients 202 
hospitalized in specific institutions as well as due to different structures and missions 203 
of hospitals. There is no defined benchmark for antibiotic use for specific categories 204 
of hospitals (e.g. primary, secondary or tertiary care). The case mix index (CMI) is an 205 
economical surrogate marker used to describe the average morbidity of patients in 206 
hospitals. We found a moderate correlation between antibiotic use and CMI when 207 
analyzing data of different departments and units of a tertiary care university hospital, 208 
as well as when comparing another 12 primary and secondary acute care hospitals in 209 
the Canton of Zurich, a state in Northern Switzerland. Such correlations were found 210 
when antibiotic use was calculated both in DDD/100 bed-days and in DDD/100 211 
admissions. Consequently, we demonstrate that differences in antibiotic use in 212 
different wards as well as in various hospitals can be explained to a significant extent 213 
by differences in CMIs of patient populations admitted to individual hospitals, and 214 
thus by differences in patients' morbidities.  215 
Data on the correlation of cost indicators and antibiotic use are scarce in the 216 
current literature. To the best of our knowledge, we present the first study to evaluate 217 
such a correlation between CMI and antibiotic use within a single institution, and 218 
across various acute care hospitals. Previously, associations between CMI and 219 
antibiotic use have been studied in long-term care settings.20, 21 Mylotte et al. 220 
reported the mean facility CMI (using the so-called Resource Utilization Groups II 221 
system) and the mean facility infection rate to significantly predict mean incidence of 222 
antibiotic use in a multilinear model. Furthermore, a trend toward a significant 223 
correlation between CMI and antibiotic use was observed by simple linear regression 224 
analysis.20 In another study, these authors found that after controlling for case mix 225 
   
variation and cost per antibiotic-day, variation in infection rate explained most of the 226 
variation in incidence of antibiotic use.21 227 
Our findings have the potential to introduce a novel method to detect variations in 228 
antibiotic prescribing within and between hospitals. Interpreting quantitative antibiotic 229 
use data of various hospital units that belong to different medical specialties is 230 
challenging due to the lack of possibilities to comprehensively measure, score and 231 
compare morbidities of all individual hospitalized patients. However, the identification 232 
of high antibiotic use on a hospital unit level may indicate inappropriate use and is 233 
furthermore crucial in order to detect areas with high antimicrobial selection pressure. 234 
Other reasons for variations in antibiotic prescribing include differences in physician 235 
prescribing preference or varying infection prevalence among hospital departments 236 
or hospitals. At present, however, no straightforward tools for continuous monitoring 237 
of infection prevalence in hospitals are available. Most hospitals assess the rate of 238 
nosocomial infections using periodic prevalence surveys. 239 
Our approach identified hospital units where quantitative antibiotic use data cannot 240 
be explained by a high case mix index. This quantitative signal now necessitates 241 
further individualized qualitative analyses in order to define whether interventions are 242 
required to improve antibiotic use in these units. Furthermore, this principle can also 243 
be applied to compare antibiotic use data between hospitals of a district or on a 244 
national level taking into account different patient populations across various 245 
hospitals. However, the manner in which cost data are collected and reimbursement 246 
rates are calculated was shown to differ among various countries,19 limiting 247 
international comparisons.  248 
Limitations of our study arise from shortcomings of methods to calculate antibiotic 249 
use and CMI. Databases for DDDs as well as for DRGs are updated regularly, i.e. 250 
definitions and variables change over time. Consequently, such updates may affect 251 
   
analyses of CMI and antibiotic use, and its correlation, when different observation 252 
periods are compared. Therefore, we repeated weighted regression analyses of the 253 
University Hospital data sets for the years 2004 and 2005 (using version 4.1 of the 254 
APDRG Swiss cost weights) and confirmed the significant correlation between 255 
antibiotic use and CMI: In 2004, the correlations between CMI and DDD/100 bed-256 
days and DDD/100 admissions resulted in R2 = 0.69 (p < 0.0001) and R2 = 0.53 (p = 257 
0.0004), respectively; and in 2005 the corresponding results were R2 = 0.72 (p < 258 
0.0001) and R2 = 0.56 (p = 0.0004). Concerning antibiotic use, the bone marrow 259 
transplantation unit is an outlier among the departments of the university hospital, 260 
which might bias the correlation between the different hospitals of the Canton of 261 
Zurich. However, even if the bone marrow transplantation unit was excluded from the 262 
university hospital data, there was still a significant correlation between CMI and 263 
antibiotic use presented in the DDD/100 bed-days format (R2 = 0.41, p = 0.0113, 264 
slope = 45.38 DDD/100 bed-days per CMI (95% CI 12.50 - 78.26)) as well as in the 265 
DDD/100 admissions format (R2 = 0.82, p < 0.0001, slope = 386.04 DDD/100 266 
admissions per CMI (95% CI 272.77 - 499.31)) for the thirteen hospitals of the 267 
Canton of Zurich.    268 
The ATC/DDD system is the well accepted and widely used standard method for 269 
measuring antibiotic use but some limitations have been discussed.4, 13, 25 For 270 
example, calculations of DDD/100 bed-days and DDD/100 admissions result in 271 
discrepant antibiotic use data because of the influence of length of stay (LOS). 272 
Hospitals with a short mean LOS have a low antibiotic use when measured in 273 
DDD/100 admissions as opposed to DDD/100 bed-days, whereas hospitals with a 274 
long mean LOS (resulting in fewer admissions) show a relatively high antibiotic use, if 275 
measured in DDD/100 admissions. LOS is largely influenced by the type of services 276 
offered by a given hospital. If long term care facilities or psychiatry wards are part of 277 
   
an acute care hospital, this results in a high mean length of stay of these institutions, 278 
as relatively few patients in these units contribute a large number of bed-days. 279 
Nevertheless, we found both variables, DDD/100 bed-days and DDD/100 280 
admissions, to similarly correlate with CMI. Furthermore, also cost weights are 281 
influenced by length of hospital stay. Procedures or diseases requiring a long 282 
hospital stay are therefore assigned a higher cost weight irrespective of the clinical 283 
judgment of the severity of a disease. The costs of implants might further bias case 284 
mix calculations. As an example, implantable cardioverter-defibrillators are more 285 
expensive than pacemakers, whereas length of stay for the implantation or the type 286 
of complications arising from the underlying arrhythmias are similar. As it must be a 287 
prerequisite for a benchmark to be easily available, we did not make attempts to 288 
control for these biases, e.g. by excluding patients with implants or with 289 
extraordinarily long hospitalisations. Finally, whereas All Patient-Refined Diagnosis-290 
Related Groups (APR-DRGs) are used in the United States to compare hospital 291 
performance by risk-adjusting mortaliy, length of stay or inpatient charges,26 it has 292 
not yet been formally evaluated whether APDRGs indeed provide a reliable estimate 293 
of patient morbidity and mortality.  294 
Other surrogate markers for case mix adjustment of hospital antibiotic use have 295 
been proposed. Lamoth et al. observed that the numbers of blood samples drawn for 296 
bacterial culture enabled accurate identification of periods with a drift in antibiotic 297 
consumption in a medical ward.27 However, the authors stated that it was uncertain 298 
whether these results could be generalised to other settings, having found that the 299 
principle could not be applied in a general surgery ward. A few other studies have 300 
approached the problem of comparing different hospitals and different patient 301 
populations by categorizing hospitals according to their size or type,28, 29 whereas 302 
   
others aimed for normalization by comparing antibiotic use among single medical 303 
specialties.29-31  304 
In conclusion, the case mix index based on DRGs may be a valuable tool to 305 
facilitate the interpretation of quantitative hospital antibiotic use data and to identify 306 
areas of concern. Advantages of this measure are that it can be obtained more easily 307 
than laborious morbidity scores, that it is based on nationwide economical data, and 308 
that it appears to generate more generalizable datasets than self-defined case mix 309 
measures.15, 27, 32 Further studies are needed to determine the role of the various 310 
measures that are proposed for the interpretation of quantitative antibiotic use, to 311 
assess the generalizability of our results, and to compare CMI and DRGs (or similar 312 
systems) of different countries with hospital antibiotic use. 313 
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Figure legends 412 
Figure 1. Antibiotic use 413 
A, Units of university hospital: 1, bone marrow transplantation unit (length of stay 414 
(LOS) = 20.8 days). 2 to 7, intensive dare units (ICUs) ordered by increasing 415 
mean LOS: 2, neurosurgical ICU (LOS, 3.1 days); 3, cardiac surgery ICU 416 
(LOS, 3.5 days); 4, medical ICU (LOS, 3.6 days); 5, general, thoracic and 417 
transplant surgery ICU (LOS, 4.2 days); 6, trauma ICU (LOS, 4.3 days); 7, 418 
burn ICU (LOS, 5.8 days); 8 to 18, different wards of departments, ordered by 419 
increasing mean LOS: 8, ophthalmology/ear-nose-throat (LOS, 3.0 days); 9, 420 
urology (LOS, 3.6 days); 10, gynaecology and obstetrics (LOS, 4.1 days); 11, 421 
surgery (cardiac, thoracic, visceral, trauma and reconstructive surgery) (LOS, 422 
4.3 days); 12, neurosurgery (LOS, 4.3 days); 13, neurology (LOS, 4.8 days); 423 
14, internal medicine (LOS, 5.3 days); 15, interdisciplinary private wards (LOS, 424 
5.3 days); 16, dermatology (LOS, 6.9 days); 17, radiation therapy (LOS, 7.8 425 
days); 18, rheumatology (LOS, 11.5 days). 426 
B, All hospitals: 1-10, primary care hospitals, ordered by increasing mean length of 427 
stay (LOS). LOS of different hospitals are 4.3, 5.8, 5.8, 5.8, 6.0, 6.3, 6.3, 6.6, 428 
10.4 and 18.4 days, respectively. 11 and 12, secondary care hospitals, 429 
ordered by increasing mean LOS. LOS of different hospitals are 6.8 and 7.6 430 
days, respectively. 13, tertiary care university hospital (LOS, 7.2 days). 431 
 432 
Figure 2. Correlation between antibiotic use and case mix index in a tertiary 433 
care university hospital. 434 
Correlation between antibiotic use and case mix index (CMI) in different wards of the 435 
University Hospital Zurich in 2006 measured in DDD/100 bed-days (upper panel) and 436 
   
DDD/100 admissions (lower panel). Weighted linear regression was used with the 437 
size of the dots corresponding to the number of bed-days.  438 
Abbreviations: DDD = Defined Daily Dose, 'Antibiotics' are all substances of ATC 439 
group 'J01 (Antibacterials for systemic use)' 440 
 441 
Figure 3. Correlation between antibiotic use and case mix index in 13 acute 442 
care hospitals. 443 
Correlation between case mix index (CMI) and antibiotic use in 2006 in various 444 
hospitals of the greater Zurich area measured in DDD/100 bed-days (upper panel) 445 
and DDD/100 admissions (lower panel). Weighted linear regression was used with 446 
the size of the dots corresponding to the number of bed-days. 447 
Abbreviations: DDD = Defined Daily Dose; 'Antibiotics' are all substances of ATC 448 
group 'J01 (Antibacterials for systemic use)' 449 
 450 
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